Johnson & Johnson (JNJ)
Company | Ticker | Sector | Industry | Quality | PAR |
---|---|---|---|---|
Johnson & Johnson | JNJ | Healthcare | Drug Manufacturers - General | 94 | 8.0% |
Current Price ( 3/18 4:00PM EDT) | $156.76 | |||
CAPS Rating (Rate this stock on CAPS) | ||||
Expected Income Statement | ||||
Current Sales | 93,022.0 | |||
Sales Growth Forecast | 3.0% | |||
Net Profit Margin | 29.6% | |||
Projected Shares Outstanding | 2,375.83 | |||
EPS - Five year Forecast | $13.44 | |||
Average P/E Ratio | 15.0 | |||
Projected Average Price | $201.65 | |||
Price Appreciation (Annualized) | 5.2% | |||
Annual Dividend Yield | 2.8% | |||
Projected Annual Return | 8.0% | |||
Quality | ||||
Financial Strength | 99 | 24.7 | ||
EPS Stability | 89 | 22.3 | ||
Industry Sales Growth Rate | 4.0% | 9.4 | ||
Industry Net Profit Margin | 19.3% | 19.2 | ||
Calculated Quality Rating | 75.5 | |||
Fool CAPS | ||||
Total Players
13598
Outperforms
513
Underperforms
All-Stars (2414)
2346
Outperforms (97%)
68
Underperforms
|
||||
Fundamental Data Updated: 02/09/2024 |